| 000 | 04866nam a22003855i 4500 | ||
|---|---|---|---|
| 999 |
_c76158 _d76158 _x1 |
||
| 001 | 76158 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040211.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 140822s2014 xxu| s |||| 0|eng d | ||
| 020 | _a9781493912278 | ||
| 024 | 7 |
_a10.1007/978-1-4939-1227-8 _2doi |
|
| 040 |
_bspa _dES-MaUEC |
||
| 050 | 4 |
_aQP114.M48 _bL673 2014 |
|
| 082 | 0 | 4 | _223 |
| 100 | 1 |
_aLopaschuk, Gary D. _eeditor. _934130 _0comprobar BNE20021481824 |
|
| 245 | 1 | 0 |
_aCardiac Energy Metabolism in Health and Disease _cedited by Gary D. Lopaschuk, Naranjan S. Dhalla. |
| 260 |
_aNew York _bSpringer _c2014 |
||
| 300 |
_a1 recurso en línea (XV, 295 p.) _b54 ilustraciones, 25 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 1 |
_aAdvances in Biochemistry in Health and Disease _v11 |
|
| 505 | 0 | _aPart 1.Â{u3BEE}ntrol of Energy Metabolism -- 1. A Primer on Carbohydrate Metabolism in the Heart -- 2. Lipoproteins: A Source of Cardiac Lipids -- 3. Role of Lipoprotein Lipase in Fatty Acid Delivery to the Heart -- 4. Control of Myocardial Fatty Acid Uptake -- 5. Cardiac Energy Metabolism in Heart Failure Associated with Obesity and Diabetes -- 6. Transcriptional Control of Mitochondrial Biogenesis and Maturation -- 7. Relationship between Substrate Metabolism and Cardiac Efficiency -- 8. Acetylation in the Control of Mitochondrial Metabolism and Integrity -- Part 2. Alteration in Energy Metabolism -- 9. Adrenergic Control of Cardiac Fatty Acid Oxidation in Diabetes -- 10. The Myocardial Creatine Kinase System in the Normal, Ischaemic and Failing Heart -- 11. Fuel Metabolism Plasticity in Pathological Cardiac Hypertrophy and Failure -- 12. Defects in Mitochondrial Oxidative Phosphorylation in Hearts Subjected to Ischemia-Reperfusion Injury -- 13. The Role of AMPK in the Control of Cardiac Hypertrophy -- 14. The Role of Incomplete Fatty Acid Oxidation in the Development of Cardiac Insulin Resistance -- Part 3. Optimization of Energy Metabolism -- 15. Metabolic Therapy for the Ischemic Heart -- 16. Inhibition of Fatty Acid Oxidation to Treat Heart Failure in Patients -- 17. Cardiac Metabolic Protection for the Newborn Heart -- 18. Targeting Transcriptional Control of Fatty Acid Oxidation to Treat Heart Disease. | |
| 520 | _aThe heart has a very high energy demand but very little energy reserves. In order to sustain contractile function, the heart has to continually produce a large amount of ATP.The heart utilizes free fatty acids mainly and carbohydrates to some extent as substrates for making energy, and any change in this energy supply can seriously compromise cardiac function.Â{u0274} has emerged that alterations in cardiac energy metabolism are a major contributor to the development of a number of different forms of heart disease.Â{u0274} is also now known that optimizing energy metabolism in the heart is a viable and important approach to treating various forms of heart disease. Cardiac Energy Metabolism in Health and Disease describes the research advances that have been made in understanding what controls cardiac energy metabolism at molecular, transcriptional, and physiological levels.Â{u0274} also describes how alterations in energy metabolism contribute to the development of heart dysfunction, and how optimization of energy metabolism can be used to treat heart disease.The topics covered include a discussion of the effects of myocardial ischemia, diabetes, obesity, hypertrophy, heart failure, and genetic disorders of mitochondrial oxidative metabolism on cardiac energetics.The treatment of heart disease by optimizing energy metabolism is also discussed, which includes increasing overall energy production as well as increasing the efficiency of energy production and switching energy substrate preference of the heart. This book will be a valuable source of information to graduate students, postdoctoral fellows, and investigators in the field of experimental cardiology as well as biochemists, physiologists, pharmacologists, cardiologists, cardiovascular surgeons and other health professionals. | ||
| 650 | 7 |
_2embne _9672862 _aCorazón _xFisiopatología |
|
| 700 | 1 |
_aDhalla, Naranjan S. _eeditor literario _0Local _984616 |
|
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4939-1227-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12817764 _b10-10-17 _c01-10-14 |
||
| 942 |
_2lcc _cLE |
||
| 945 |
_aQP114.M48 L673 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11546980 _z06-04-17 |
||
| 988 | _aEBSPRINGER | ||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gxxu _h0 |
||